BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Powered by Business Wire
Biotechnology Headlines

Medical Device Innovation Consortium Announces CEO William V. Murray is Stepping Down to Return to Private Sector; Board Begins Search for New Leader

ARLINGTON, Va.--(BUSINESS WIRE)--The Medical Device Innovation Consortium (MDIC) CEO William V. (Bill) Murray today announced he will step down as President & CEO effective February 2, 2018 to return to the private sector. Stated Murray, “Over the past four years, it has been my honor and privilege to lead MDIC as we have grown from concept to an established part of the ecosystem in accelerating patient access to safe and effective life changing innovation. I am extremely proud of what we have accomplished.” Murray continued, “The organization is fortunate to be led by a board of senior leaders throughout the medtech ecosystem, supported by an incredible group of member volunteers and dedicated MDIC staff that give me great confidence we will achieve a smooth transition.”

“The organization has evolved into an integral partner with patients, industry and the FDA in addressing the most challenging regulatory science issues required for faster, safer and more efficient development, assessment and review of life-changing medical technologies. The FDA looks forward to continued collaborations with MDIC and its new leadership.”

“The Board of Directors for MDIC would like to thank Bill for his leadership and contribution to advancing regulatory science for patients and expanding into real world data coordination,” said MDIC Board Chairman Mike Minogue, President, CEO and Chairman of Abiomed. “We wish him well going forward as he returns to the private sector to pursue other opportunities.”

“MDIC has made great progress under Bill’s leadership these past four years,” said Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health. “The organization has evolved into an integral partner with patients, industry and the FDA in addressing the most challenging regulatory science issues required for faster, safer and more efficient development, assessment and review of life-changing medical technologies. The FDA looks forward to continued collaborations with MDIC and its new leadership.”

Murray added, “My decision to return to the private sector has been difficult and emotional; we have built something very unique and rewarding at MDIC. Announcing my intention 3 months prior to leaving was the right decision to allow MDIC to move forward in a planned manner.” Murray closed by saying, “I want to thank the MDIC Board for their support as I worked through this process.”

The MDIC Board today also announced it has initiated a search for the next CEO. Stated Minogue, “MDIC is an integral part of the medtech ecosystem, the Board is committed to find the next CEO leader that has the vision, passion and commitment to build on MDIC’s success.”

About Medical Device Innovation Consortium
Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market. For more information, visit www.mdic.org.

Contacts

Medical Device Innovation Consortium
Gillian Priddy, 952-314-1255
ExecutiveAdmin@mdic.org
www.mdic.org